Cell-penetrating-peptide-mediated siRNA lung delivery
- 20 July 2007
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 35 (4), 807-810
- https://doi.org/10.1042/bst0350807
Abstract
The therapeutic application of siRNA (short interfering RNA) shows promise as an alternative approach to small-molecule inhibitors for the treatment of human disease. However, the major obstacle to its use has been the difficulty in delivering these large anionic molecules in vivo. A potential approach to solving this problem is the chemical conjugation of siRNA to the cationic CPPs (cell-penetrating peptides), Tat-(48–60) (transactivator of transcription) and penetratin, which have been shown previously to mediate protein and peptide delivery in a host of animal models. In this transaction, we review recent studies on the utility of siRNA for the investigation of protein function in the airways/lung. We show that, despite previous studies showing the utility of cationic CPPs in vitro, conjugation of siRNA to Tat-(48–60) and penetratin failed to increase residual siRNA-mediated knockdown of p38 MAPK (mitogen-activated protein kinase) (MAPK14) mRNA in mouse lung in vivo. Significantly, we will also discuss potential non-specific actions and the induction of immunological responses by CPPs and their conjugates and how this might limit their application for siRNA-mediated delivery in vivo.Keywords
This publication has 43 references indexed in Scilit:
- Endothelial STAT3 is essential for the protective effects of HO‐1 in oxidant‐induced lung injuryThe FASEB Journal, 2006
- Suppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung InflammationPublished by The American Association of Immunologists ,2006
- IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosisNature Medicine, 2005
- Translating RNA Interference into Therapies for Human DiseasePharmacogenomics, 2005
- First clinical data on RNAiDrug Discovery Today, 2005
- RNA interference and potential therapeutic applications of short interfering RNAsCancer Gene Therapy, 2005
- siRNA for gene silencing: a route to drug target discoveryCurrent Opinion in Pharmacology, 2004
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004
- Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung ApoptosisJournal of Biological Chemistry, 2004
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001